Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer Inks Marketing Pact With Claris
The deal extends reach of Claris’s products in Europe, North America and Australia. Pfizer will undertake the commercialisation of the products that have gone off-patent in the western
The deal extends reach of Claris’s products in Europe, North America and Australia. Pfizer will undertake the commercialisation of the products that have gone off-patent in the western
Advaxis’ bioengineered Listeria monocytogenes (Lm) carrier system will be used with Collaborator’s influenza multi-antigen technology to produce oral vaccine against influenza. Thomas A. Moore, CEO of Advaxis, said:
Insight enables healthcare institutions to monitor, measure and analyse over 1000 vital financial and clinical performance indicators. Insight is installed in over 100 hospital facilities. Thomas Mann, President
William Shirey, Executive VP of BDI, said: “The fact that our company’s sales for XYNTHA have tracked twenty-two percent (22%) ahead of the results forecasted for the first
Jeffrey M. Yordon, CEO of Sagent, said: “Since our inception in 2006, Sagent has successfully executed its strategy by filing more than 70 aNDAs to date, with more
The drug is designed to block production of a protein that carries LDL cholesterol in the blood. It met its primary goal in a study of 51 patients
The regulatory submission has been filed in the UK and Spain under the European decentralised procedure. The UK regulatory authority, the Medicines and Healthcare products Regulatory Agency (MHRA),
The drug is being manufactured jointly by Bayer HealthCare and Onyx Pharmaceuticals. The approval was based on a positive data from the international, Phase III double-blind, placebo-controlled Sorafenib
Enzyme replacement therapy for the treatment of HPP is the company’s lead program. The FDA has granted fast track designation in part because HPP is an untreated, serious
The company took this step in response to an appeal made by the UN and WHO to drug makers to save some of their pandemic vaccines for poor